Evidence map›Paper›PMID 28691794›Full record

ArticleACS chemical neuroscience2017

Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization.

Marcel Scheepstra, Sebastian A Andrei, Rens M J M de Vries, Femke A Meijer, Jian-Nong Ma, Ethan S Burstein, Roger Olsson, Christian Ottmann, Lech-Gustav Milroy, Luc Brunsveld

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Regulation ofInternational journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring Ligand Binding Domain Dynamics in the NRs Superfamily.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Marcel ScheepstraDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
Sebastian A AndreiDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
Rens M J M de VriesDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
Femke A MeijerDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
Jian-Nong MaACADIA Pharmaceuticals Inc., San Diego, California 92130, United States.
Ethan S BursteinACADIA Pharmaceuticals Inc., San Diego, California 92130, United States.
Roger OlssonChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University , SE-221 00 Lund, Sweden.
Christian OttmannDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.ORCID 0000-0001-7315-0315
Lech-Gustav MilroyDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
Luc BrunsveldDepartment of Biomedical Engineering and Institute for Complex Molecular Systems, Laboratory of Chemical Biology, Technische Universiteit Eindhoven , Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.ORCID 0000-0001-5675-511X
Eindhoven University of Technology · NLAcadia Pharmaceuticals (United States) · USLund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoid X receptors (RXRs) play key roles in many physiological processes in both the periphery and central nervous system. In addition, RXRs form heterodimers with other nuclear receptors to exert their physiological effects. The nuclear receptor related 1 protein (NURR1) is particularly interesting because of its role in promoting differentiation and survival of dopamine neurons. However, only a small number of RXR-heterodimer selective modulators are available, with limited chemical diversity. This work describes the synthesis, biochemical evaluation, and structural elucidation of a novel series of RXR ligands with strongly biased interactions with RXRα-NURR1 heterodimers. Targeted modifications to the small molecule biaryl scaffold caused local RXRα side-chain disturbances and displacement of secondary structural elements upon ligand binding. This resulted in the repositioning of protein helices in the heterodimer interface of RXRα, alterations in homo- versus heterodimer formation, and modulation of activation function 2 (AF2). The data provide a rationale for the design of RXR ligands consisting of a highly conserved hydrophilic region, strongly contributing to the ligand affinity, and a variable hydrophobic region, which efficiently probes the effects of structural changes at the level of the ligand on co-regulator recruitment or the RXRα-NURR1 dimerization interface.

Indexed as

Drug DesignEscherichia coliEstersEthersHumansHydrogen BondingLigandsModels, MolecularMolecular StructureNuclear Receptor Subfamily 4, Group A, Member 2Protein BindingProtein MultimerizationRetinoid X Receptor alphaTwo-Hybrid System TechniquesEstersEthersLigandsNuclear Receptor Subfamily 4, Group A, Member 2Retinoid X Receptor alphaheterodimerizationligand binding domainnuclear receptor related 1Nuclear receptorsretinoid X receptor

Identifiers

PMID28691794
PMCPMC5609127
OpenAlexW2735052425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.